Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.
Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O'Carrol C, Atakan Z, Zuardi AW, McGuire P. Fusar-Poli P, et al. Among authors: bhattacharyya s. Int J Neuropsychopharmacol. 2010 May;13(4):421-32. doi: 10.1017/S1461145709990617. Epub 2009 Sep 24. Int J Neuropsychopharmacol. 2010. PMID: 19775500 Free article. Clinical Trial.
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O' Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Bhattacharyya S, et al. Neuropsychopharmacology. 2010 Feb;35(3):764-74. doi: 10.1038/npp.2009.184. Epub 2009 Nov 18. Neuropsychopharmacology. 2010. PMID: 19924114 Free PMC article. Clinical Trial.
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms.
Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen R, Holt D, Wilson D, Sumich A, McGuire P, Murray RM, Kapur S, Ffytche DH. Morrison PD, et al. Among authors: bhattacharyya s. Neuropsychopharmacology. 2011 Mar;36(4):827-36. doi: 10.1038/npp.2010.222. Epub 2010 Dec 8. Neuropsychopharmacology. 2011. PMID: 21150914 Free PMC article. Clinical Trial.
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
Winton-Brown TT, Allen P, Bhattacharyya S, Borgwardt SJ, Fusar-Poli P, Crippa JA, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Winton-Brown TT, et al. Among authors: bhattacharyya s. Neuropsychopharmacology. 2011 Jun;36(7):1340-8. doi: 10.1038/npp.2011.17. Epub 2011 Mar 16. Neuropsychopharmacology. 2011. PMID: 21412224 Free PMC article. Clinical Trial.
Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
Bossong MG, Jansma JM, Bhattacharyya S, Ramsey NF. Bossong MG, et al. Among authors: bhattacharyya s. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:53-69. doi: 10.1016/j.pnpbp.2013.11.017. Epub 2013 Dec 29. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24380726 Review.
Cannabis use and transition to psychosis in people at ultra-high risk.
Valmaggia LR, Day FL, Jones C, Bissoli S, Pugh C, Hall D, Bhattacharyya S, Howes O, Stone J, Fusar-Poli P, Byrne M, McGuire PK. Valmaggia LR, et al. Among authors: bhattacharyya s. Psychol Med. 2014 Sep;44(12):2503-12. doi: 10.1017/S0033291714000117. Psychol Med. 2014. PMID: 25055169
2,296 results